Trends and Barriers of Medication Treatment for Opioid Use Disorders: A Systematic Review and Meta-Analysis

Adherence to and retention in Medication Treatment for Opioid Use Disorders (MOUD) persist. We systematically reviewed trends of USA MOUD adherence, retention, and barriers from 2011–2021. Primary outcomes were adherence to and retention in MOUD, abstinence, adverse events, and treatment barriers. E...

Full description

Saved in:  
Bibliographic Details
Main Author: Hutchison, Morica (Author)
Contributors: Russell, Beth S. ; Leander, Abigail ; Rickles, Nathaniel ; Aguiar, Derek ; Cong, Xiaomei S. ; Harel, Ofer ; Hernandez, Adrian V.
Format: Electronic Article
Language:English
Published: 2025
In: Journal of drug issues
Year: 2025, Volume: 55, Issue: 2, Pages: 193-214
Online Access: Volltext (lizenzpflichtig)
Journals Online & Print:
Drawer...
Check availability: HBZ Gateway
Keywords:
barriers to treatment
Systematic Review
Meta-analysis
medications for opioid use disorders

MARC

LEADER 00000naa a22000002c 4500
001 1919388958
003 DE-627
005 20250309054815.0
007 cr uuu---uuuuu
008 250309s2025 xx |||||o 00| ||eng c
024 7 |a 10.1177/00220426231204841  |2 doi 
035 |a (DE-627)1919388958 
035 |a (DE-599)KXP1919388958 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 2,1  |2 ssgn 
100 1 |a Hutchison, Morica  |e VerfasserIn  |0 (orcid)0000-0002-0807-8721  |4 aut 
245 1 0 |a Trends and Barriers of Medication Treatment for Opioid Use Disorders: A Systematic Review and Meta-Analysis 
264 1 |c 2025 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Adherence to and retention in Medication Treatment for Opioid Use Disorders (MOUD) persist. We systematically reviewed trends of USA MOUD adherence, retention, and barriers from 2011–2021. Primary outcomes were adherence to and retention in MOUD, abstinence, adverse events, and treatment barriers. Effects of inverse variance random meta-analyses were examined using proportions and 95% CIs. 28 studies (102,318 patients), 78.1% male. Adherence was 56% across all studies, highest for methadone (73%). Retention by study design was heterogeneous: case series (57%), cohorts (47%), and RCTs (70%). The most common barriers were younger age, comorbid diagnoses, daily attendance, no insurance, and transportation. Abstinence was 72%, and adverse events was 5%. There was high heterogeneity in MOUD across drug types and study designs. Our findings extend the knowledge base of MOUD treatment to describe barriers that underpin the focus on retention in care above adherence given its focus to harm reduction principles. 
650 4 |a barriers to treatment 
650 4 |a Systematic Review 
650 4 |a Meta-analysis 
650 4 |a medications for opioid use disorders 
700 1 |a Russell, Beth S.  |e VerfasserIn  |4 aut 
700 1 |a Leander, Abigail  |e VerfasserIn  |4 aut 
700 1 |a Rickles, Nathaniel  |e VerfasserIn  |4 aut 
700 1 |a Aguiar, Derek  |e VerfasserIn  |4 aut 
700 1 |a Cong, Xiaomei S.  |e VerfasserIn  |4 aut 
700 1 |a Harel, Ofer  |e VerfasserIn  |0 (DE-588)1357424787  |0 (DE-627)1917896050  |4 aut 
700 1 |a Hernandez, Adrian V.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of drug issues  |d Thousand Oaks, Calif. : Sage, 1971  |g 55(2025), 2, Seite 193-214  |h Online-Ressource  |w (DE-627)331258277  |w (DE-600)2051257-0  |w (DE-576)260774243  |x 1945-1369  |7 nnas 
773 1 8 |g volume:55  |g year:2025  |g number:2  |g pages:193-214 
856 4 0 |u https://doi.org/10.1177/00220426231204841  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
935 |a mkri 
951 |a AR 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4685427793 
LOK |0 003 DE-627 
LOK |0 004 1919388958 
LOK |0 005 20250309043607 
LOK |0 008 250309||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-2619)KrimDok#2025-03-08#8DC52E25F7A318F8A0CA9B37502A82A4DC2E95ED 
LOK |0 040   |a DE-2619  |c DE-627  |d DE-2619 
LOK |0 092   |o n 
LOK |0 852   |a DE-2619 
LOK |0 852 1  |9 00 
LOK |0 935   |a zota 
ORI |a SA-MARC-krimdoka001.raw